Tsou Terrence C, Ray Shagnik, Maruf Mahir, Kohn Taylor P, Zaman Mohammad H, Ayenew Michael F, George Arvin K, Herati Amin S
The James Buchanan Brady Urological Institute, The Johns Hopkins University School of Medicine, Baltimore, MD.
Department of Urology, The Ohio State University Wexner Medical Center, Columbus, OH.
J Mens Health. 2024 Nov;20(11):19-27. doi: 10.22514/jomh.2024.182. Epub 2024 Nov 29.
Intracytoplasmic sperm injection (ICSI) is a cornerstone in managing male infertility, especially in obstructive azoospermia (OA) and non-obstructive azoospermia (NOA), necessitating sperm retrieval via testicular sperm extraction (TESE) or microdissection TESE (mTESE). However, the varied post-sperm extraction processing methods pose uncertainty regarding optimal approaches. To address this, a systematic review following preferred reporting items for systematic review and meta-analysis protocols (PRISMA-P) guidelines was conducted, identifying 16 relevant studies. These studies exhibited significant heterogeneity in methodologies and outcomes, with mechanical preparation and enzymatic digestion being the primary techniques investigated. Mechanical methods, including shredding, mincing, vortexing, and crushing, yielded varying sperm counts per 100 mg of tissue, with mincing showing promise in NOA cases. Enzymatic digestion, particularly with collagenase type IV, also showed effectiveness, though inconsistently. Additionally, techniques such as microfluidics and magnetic levitation showed potential for improving sperm retrieval efficiency. However, the lack of standardization in outcomes and reporting impedes the establishment of best practice protocols. While collagenase type IV with elastase seemed promising for OA samples and microfluidics for NOA cases, further studies with standardized methodologies and outcomes are necessary. Assessment of DNA damage and comparisons of ICSI success rates between processing methods are crucial for informed clinical practice. In conclusion, optimizing sperm quantity and quality for ICSI necessitates standardized methodologies and outcomes, with microfluidics and collagenase type IV with elastase showing promise pending further validation through well-designed studies.
胞浆内单精子注射(ICSI)是治疗男性不育症的基石,尤其是在梗阻性无精子症(OA)和非梗阻性无精子症(NOA)中,这需要通过睾丸精子提取(TESE)或显微切割TESE(mTESE)来获取精子。然而,精子提取后的各种处理方法在最佳方法方面存在不确定性。为了解决这个问题,我们按照系统评价和荟萃分析方案的首选报告项目(PRISMA-P)指南进行了一项系统评价,确定了16项相关研究。这些研究在方法和结果上表现出显著的异质性,机械制备和酶消化是主要研究的技术。机械方法包括切碎、切碎、涡旋和压碎,每100毫克组织产生的精子数量各不相同,切碎在NOA病例中显示出前景。酶消化,特别是使用IV型胶原酶,也显示出有效性,尽管不一致。此外,微流控和磁悬浮等技术显示出提高精子提取效率的潜力。然而,结果和报告缺乏标准化阻碍了最佳实践方案的建立。虽然IV型胶原酶与弹性蛋白酶对OA样本似乎有前景,微流控对NOA病例有前景,但需要进一步开展方法和结果标准化的研究。评估DNA损伤以及比较处理方法之间的ICSI成功率对于明智的临床实践至关重要。总之,为ICSI优化精子数量和质量需要标准化的方法和结果,微流控以及IV型胶原酶与弹性蛋白酶在经过精心设计的研究进一步验证之前显示出前景。